Underexplored Opportunities for Natural Products in Drug Discovery

被引:105
作者
DeCorte, Bart L. [1 ]
机构
[1] Janssen Pharmaceut Co Johnson & Johnson, 1400 McKean Rd, Spring House, PA 19477 USA
关键词
DIVERSITY-ORIENTED SYNTHESIS; OSELTAMIVIR PHOSPHATE TAMIFLU; CELL-CYCLE ARREST; MOLECULAR-CLONING; BIOLOGY; BIOSYNTHESIS; DIOSGENIN; APOPTOSIS; LIBRARY; COMPLEX;
D O I
10.1021/acs.jmedchem.6b00473
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The importance of natural products in the treatment of human disease is well documented. While natural products continue to have a profound impact on human health, chemists have succeeded in generating semisynthetic analogues that sometimes overshadow the original natural product in terms of clinical significance. Synthetic efforts based on natural products have primarily focused on improving their drug-like features while targeting utility in the same biological space. A less documented phenomenon is that natural products can serve as powerful starting materials to generate drug substances with novel therapeutic utility that is unrelated to the biological space of the natural product starting material. In this Perspective, examples of natural product derived marketed drugs with therapeutic utility in clinical space that is different from the biological profile of the starting material are presented, demonstrating that this is not merely a theoretical concept but both a clinical reality and an underexplored opportunity.
引用
收藏
页码:9295 / 9304
页数:10
相关论文
共 108 条
  • [41] The morphine group. Part I. A discussion of the constitutional problem.
    Gulland, JM
    Robinson, R
    [J]. JOURNAL OF THE CHEMICAL SOCIETY, 1923, 123 : 980 - 998
  • [42] Hare Ronald., 1970, The Birth of Penicillin and the Disarming of Microbes
  • [43] Secramine inhibits Cdc42-dependent functions in cells and Cdc42 activation in vitro
    Henry, EP
    Peterson, JR
    Salvarezza, SB
    Rodriguez-Boulan, E
    Chen, JL
    Stamnes, M
    Macia, E
    Feng, Y
    Shair, MD
    Kirchhausen, T
    [J]. NATURE CHEMICAL BIOLOGY, 2006, 2 (01) : 39 - 46
  • [44] Synthesis of Bridged Oxafenestranes from Pleuromutilin
    Hicklin, Robert W.
    Lopez Silva, Tania L.
    Hergenrother, Paul J.
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (37) : 9880 - 9883
  • [45] Principles of early drug discovery
    Hughes, J. P.
    Rees, S.
    Kalindjian, S. B.
    Philpott, K. L.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (06) : 1239 - 1249
  • [46] Huigens RW, 2013, NAT CHEM, V5, P195, DOI [10.1038/NCHEM.1549, 10.1038/nchem.1549]
  • [47] Direct Access to 6/5/7/5-and 6/7/5/5-Fused Tetracyclic Triterpenoids via Divergent Transannular Aldol Reaction of Lanosterol-Derived Diketone
    Ignatenko, Vasily A.
    Han, Yong
    Tochtrop, Gregory P.
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (23) : 12229 - 12235
  • [48] Approach for Expanding Triterpenoid Complexity via Divergent Norrish-Yang Photocyclization
    Ignatenko, Vasily A.
    Tochtrop, Gregory P.
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (08) : 3821 - 3831
  • [49] Molecular Library Synthesis Using Complex Substrates: Expanding the Framework of Triterpenoids
    Ignatenko, Vasily A.
    Han, Yong
    Tochtrop, Gregory P.
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2013, 78 (02) : 410 - 418
  • [50] SAFRACINS, NEW ANTI-TUMOR ANTIBIOTICS .3. BIOLOGICAL-ACTIVITY
    IKEDA, Y
    SHIMADA, Y
    HONJO, K
    OKUMOTO, T
    MUNAKATA, T
    [J]. JOURNAL OF ANTIBIOTICS, 1983, 36 (10) : 1290 - 1294